Attached files
| file | filename |
|---|---|
| EX-31.1 - CERTIFICATE RULE 13A-14A HECTOR DAVIS, CEO, CFO - Cortronix Biomedical Advancement Technologies Inc. | certrule13a14ahectordavisceo.htm |
| 10-Q - PANA-MINERALES S.A. FORM 10-Q FEB. 28, 2011 - Cortronix Biomedical Advancement Technologies Inc. | body_panamin10qfeb2011.htm |
Exhibit 32.1
CERTIFICATE PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report (the “Report”) on the Form 10-Q of Pana-Minerales S.A. (the “Company”) for the six months ended February 28, 2011, as filed with the Securities and Exchange Commission on the date hereof, I, Hector Francisco Vazquez Davis, Chief Executive Officer, Chief Financial Officer, President, Secretary Treasurer and Director, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:
1. The Quarterly Report fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities and Exchange Act of 1934, as amended; and
2. The information contained in this Quarterly Report fairly presents, in all material respects, the financial condition and results of operation of the Company.
Date: March 14, 2011
HECTOR F. V. DAVIS
Hector Francisco Vasquez Davis
Chief Executive Officer, Chief Financial Officer
President, Secretary Treasurer and Director
-1-